November 2010 — Anthera, located in Hayward, California, has subscribed to R&D Logic software and services for planning and tracking, and financial reporting. Anthera Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products to treat serious illnesses, including cardiovascular and autoimmune diseases.

October 2010 — Adamas, a long term customer of R&D Logic, has added R&D Time to their suite of services. R&D Time is being utilized to collecting and tracking time effort, with an emphasys on NIH grants. Adamas Pharmaceuticals is an emerging pharmaceutical company focused on developing small molecule Advantaged Therapeutics. Adamas Pharmaceuticals is headquartered in Emeryville, California, with operations in Bangalore, India.

September 2010 — Trius Therapeutics, located in San Diego, California, has chosen R&D Logic software for corporate and research contracts planning and tracking, budgeting and forecasting. Trius Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics for serious, life-threatening infections.

September 2010 — Athersys, located in Cleveland, Ohio, has subscribed to R&D Logic software and services for corporate planning and tracking, and financial reporting. Athersys is a biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. Through the application of our proprietary technologies, we have established a pipeline of therapeutic product development programs in multiple disease areas.

August 2010 — "We chose R&D Logic's time collection and reporting tool because of R&D Logic's industry expertise, reputation for providing high quality software and services, and web based technology. R&D Time was implemented in less than three weeks and is now one of the key systems utilized to manage our internal resources and our collaborations with large pharmaceutical companies," says Andrew Smith, Assistant Controller of Portola Pharmaceuticals.

June 2010 — Prognosys Biosciences, located in La Jolla, California, has chosen R&D Logic software for corporate planning and tracking, financial reporting, and time collection. Prognosys is an early-stage biotechnology company focusing on the promising and rapidly developing field of personalized medicine. Prognosys carries out R&D in the area of novel assays and biomarker discovery, and uses next-generation sequencing technologies for the analysis of complex systems.

June 2010 — Wanda Ionescu's presentation on "ROI on R&D" has spurned lively discussions among the participants at the conference.

May 2010 — Hyperion Therapeutics, Inc., located in South San Francisco, California, has subscribed to R&D Logic software services to manage planning and tracking of corporate revenues, expenses and resources. Hyperion Therapeutics is a privately held pharmaceutical company focused on the development of treatments that address critical unmet needs in the areas of gastroenterology and hepatology.

April 2010 — “Our new Board members bring more than 50 years of combined experience in the Life Sciences and Software industries. These industry veterans will enable R&D Logic to continue to deliver substantial value to the Life Sciences Industry," said Wanda Ionescu, Chief Executive Officer and President, in a press release issued by R&D Logic Inc.

January 2010 — This major release features a brand new interface, along with many new user friendly features: New looks, colors, fewer clicks and streamlined navigation; New mechanism to submit and browse reports; New mechanism to list, search and update information.

January 2010 — R&D Logic CEO will moderate a roundtable discussion about "ROI on R&D" at this CPM Conference. The 2010 CPM Conference, Leveraging Analytics To Turn Data Into Insight, will focus on how companies can successfully harness data-management and business-intelligence techniques for fact-based decision-making. R&D Logic, a leader in providing inovative management solutions and services, will share its expertise and practical experience in supporting management of portolio-based companies.

September 2011 — RealD, located in Beverly Hills, California, has subscribed to R&D Logic software services to manage planning, tracking and time collection for their Colorado based Research & Development division. RealD is a leading global licensor of stereoscopic (three-dimensional), or 3D, technologies. Its extensive intellectual property portfolio enables a premium 3D viewing experience in the theater, the home and elsewhere.

September 2011 — Vitapath Genetics, Inc., located in Foster City, California, has subscribed to R&D Logic software services to manage planning, tracking, time collection and corporate reporting. VitaPath Genetics is developing a family of DNA tests to help individuals reduce the risk of serious and life-threatening disease.

August 2011 — Affymax, located in Palo Alto, California, has subscribed to R&D Time software services to manage time collection, FTE and collaborations reporting. Affymax is a biopharmaceutical company committed to developing novel drugs to improve the treatment of serious and often life-threatening conditions.The company’s product candidate, peginesatide (formerly known as HematideTM), has been investigated in Phase 3 trials for the potential treatment of anemia associated with chronic renal failure.

May 2011 — NovaBay, located in Emeryville, California, has subscribed to R&D Time software services to manage time collection and collaborations' reporting. NovaBay is a clinical stage biotechnology company focused on developing its proprietary and patented topical Aganocide compounds.

October 2012 — PNIDigitalMedia, located in Vancouver, Canada has subscribed to R&D Logic software and services for managing planning, tracking, consolidation reporting as well as time collection. At its core, PNI Digital Media provides a proprietary transactional software platform that is used by leading retailers such as Costco, Walmart Canada, and CVS/pharmacy to sell millions of personalized products every year.

October 2012 — Solazyme, located in South San Francisco, California has subscribed to R&D Logic software and services as the corporate-wide solution for collecting, managing and reporting project effort, FTEs as well as time off. Solazyme has pioneered an industrial biotechnology platform that harnesses the prolific oil-producing ability of microalgae.

September 2012 — Pfenex, located in San Diego, California, has subscribed to R&D Logic software and services for managing planning, tracking, analysis and consolidation reporting. Pfenex is a leading biotechnology company focused on recombinant protein expression for a broad range of applications including therapeutic proteins, vaccines, research, reagents and biosimilars.

August 2012 — EnVivo, located in Watertown, Massachusetts, has subscribed to R&D Logic software and services for managing FP&A corporate processes. EnVivo is developing its broad pipeline of diverse programs with a focus on leveraging novel mechanisms of action to treat CNS diseases like schizophrenia and Alzheimer’s disease in new ways and from multiple angles.

June 2012 — Epizyme, located in Cambridge, Massachusetts, has subscribed to R&D Logic software and services for planning, tracking, time collection and consolidated reporting of the R&D Portfolio and of Corporate Financials. Epizyme is leading the discovery and development of small molecule histone methyltransferase(HMT)inhibitors, a new class of personalized therapeutics for the treatment of patients with genetically-defined cancers, based on breakthroughs in the field of epigenetics.

June 2012 — AVEO, located in Cambridge, Massachusetts, has subscribed to R&D Time software services to manage time collection, FTE and collaborations reporting. AVEO Oncology is a cancer therapeutics company committed to discovering, developing and commercializing targeted therapies to impact patients’ lives.

June 2012 — With R&D GRANT, customers can ensure that funds are fully drawn and that indirect costs are recovered. 

January 2012 — OncoGenex, located in Vancouver, Canada and Seattle, Washington, has subscribed to R&D Logic software and services for planning and tracking, and financial reporting. OncoGenex Pharmaceuticals is a drug discovery and development company uniquely focused on the challenge of cancer treatment resistance.

December 2013 — Tetraphase Pharmaceuticals, located in Watertown, Massachusetts has selected R&D Logic software and services to automate FP&A processes: planning, tracking, analysis and reporting. Tetraphase is a clinical-stage biopharmaceutical company using its proprietary chemistry technology to create novel antibiotics for serious and life-threatening multi-drug resistant (MDR) infections.

December 2013 — Sarepta Therapeutics, located in Cambridge, Massachusetts has selected R&D Logic software and services to manage corporate planning, tracking, analysis and reporting. Sarepta Therapeutics is focused on developing first-in-class RNA-based therapeutics to improve and save the lives of people affected by serious and life-threatening rare and infectious diseases.

March 2013 — Enanta Pharmaceuticals, located in Watertown, Massachusetts has subscribed to R&D Logic software and services to manage corporate planning, tracking, reporting as well as time collection processes. Enanta is a research and development-focused biotechnology company that uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs in the infectious disease field.

January 2013 — BIND Biosciences, located in Cambridge, Massachusetts has subscribed to R&D Logic software and services for collecting, managing and reporting collaborator project time, project FTEs as well as time off. BIND is a clinical-stage biopharmaceutical company developing a new class of highly selective targeted therapeutics called Accurins.

November 2015 — Please click here for the press release.

November 2015 — Located in Watertown, MA, Forma Therapeutics has selected the R&D Logic FP&A solution to manage their R&D intensive company. Forma is passionate about discovering and developing medicines that will make a difference in cancer and other genetically-driven diseases.

October 2015 — Viking, located in San Diego, California has selected R&D Logic's software for planning, tracking, analysis and reporting. Viking Therapeutics is a clinical-stage biotherapeutics company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders.

September 2015 — R&D Logic once again has been asked to participate in the Southern California Regional ABFO meeting. Presenting its life science industry standard FPA solution.

May 2015 — Just, located in Seattle, Washington has selected R&D Logic's software for planning, tracking, analysis and reporting. Just is an integrated design company focused on the technology of biotherapeutics, from molecule to manufacturing plant. Just believes that technological innovation will accelerate biotherapeutic development and dramatically reduce the cost of these vital medicines.

March 2015 — Please click here for the press release.

January 2015 — Retrophin, located in New York, Cambridge and San Diego has selected R&D Logic's software for collecting and reporting R&D project effort and FTEs. Retrophin is a biopharmaceutical company focused on the discovery, acquisition, development and commercialization of drugs for the treatment of debilitating and often life-threatening diseases for which there are currently limited patient options.

December 2016 — Located in Mountain View, CA, IGM Biosciences is dedicated to helping patients world-wide by creating and developing novel IgM and IgA antibodies which improve the treatment of cancer and infectious diseases.

September 2016 — Located in Baltimore, MD, Cerecor Inc. joins the growing list of Biotech and Pharmaceutical companies convinced that doing business with a software company dedicated to life sciences is the right choice. Cerecor Inc. is a clinical-stage biopharmaceutical company with the goal of becoming a leader in the development of innovative drugs that make a difference in the lives of patients with neurological and psychiatric disorders.

August 2016 — Click here to read more.

July 2016 — Located in Cambridge, MA, Intellia Therapeutics is the most recent Biotech company to recognize R&D Logic's unique life sciences specialization. Intellia's combination of deep scientific expertise and clinical development experience, along with their leading intellectual property portfolio, puts them in a unique position to unlock broad therapeutic applications of the CRISPR/Cas9 technology and create a new class of therapeutic products.

May 2016 — This years conference will be held in San Diego from May 24th - 27th.

April 2016 — Located in Cambridge, MA, Spero Therapeutics is the latest life science company to select R&D Logic's Life Sciences specialty solution to manage their R&D intensive company. Spero's mission is to develop, and advance groundbreaking therapeutics to meet critical patient needs in infectious disease.

April 2016 — Located in Newton, MA, Karyopharm Therapeutics is the latest life science company in this explosive Biotech hub to select the R&D Logic solution to manage their R&D intensive company. Karyopharm's mission is to discover and develop first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases.

March 2016 — Located in San Bruno, CA, Balance Therapeutics has selected R&D Logic's Life Sciences specialty solution to manage their R&D intensive company. Balance is focused on developing therapeutics to address neurological disabilities resulting from excess inhibition of the brain.

January 2016 — Located in San Francisco, CA, Nurix has selected R&D Logic's Life Sciences specialty solution to manage their R&D intensive company. Nurix is passionate in its mission of pioneering the development of small molecules that modulate the ubiquitin proteasome system (UPS) for improvement of human health.

October 2017 — Founded in 1994, and located in South San Francisco, CA, Exelixis, Inc. is a commercially successful, oncology-focused biotechnology company that strives to accelerate the discovery, development and commercialization of new medicines for difficult-to-treat cancers.

July 2017 — Located in San Francisco, CA Jaguar Animal Health is developing a pipeline of prescription drug product candidates and non-prescription products to address unmet needs in animal health.

May 2017 — Located in Cambridge, MA, Warp Drive Bio operates on the core principle that nature is the most powerful inventor of new drugs, unconstrained by the boundaries of modern science.

May 2017 — This years conference will be held in Philadelphia from May 30th - June 2nd.

August 2018 — Located in Vancouver, BC, Ondine is focused on the development and commercialization of their patented light activated technology, photodisinfection. Photodisinfection provides rapid antimicrobial efficacy without encouraging the formation and spread of antibiotic resistance.

July 2018 — Located in Cambridge, MA, RA Pharma is a clinical-stage biopharmaceutical company using a proprietary peptide chemistry platform to develop novel therapeutics for the treatment of serious diseases that are caused by excessive or uncontrolled activation of the complement system.

June 2018 — Located in Richmond, CA, Sangamo Therapeutics believes, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases.

May 2018 — This year’s conference will be held in San Francisco, CA from May 29th to June 1st.

March 2018 — Located in Redwood City, CA ARMO BioSciences is a late-stage immuno-oncology company that is developing a pipeline of novel, proprietary products that activate the immune system of cancer patients to recognize and eradicate tumors.

Feburary 2018 — Located in Cambridge, MA Flagship Pioneering fueled by curiosity and a quest for new sources of future value, conceives, creates, resources and grows first-in-category life sciences companies.

January 2018 — Announcing our refined innovative Life Sciences Platform to Manage your R&D Portfolio.

December 2019 — With offices in Ottawa and New York City, Turnstone Biologics' mission is to deliver breakthrough viral immunotherapies to improve survival for patients with cancer.

June 2019 — Located in San Diego, CA, Turning Point Therapeutics has created a new generation of therapies that are different from the conventional kinase inhibitors. Their compact molecules are potentially more potent and selective medicines that also hold promise to prevent and overcome resistance.

May 2019 — R&D Logic Panel: Thursday, May 30th, at 2:15. R&D Logic Panel Discussion Topic: "Financial and Resource Management - TARGETED Reporting and Dashboards – why it matters". Review the agenda and register here.

March 2019 — Located in Cambridge, MA, Casebia combines CRISPR/Cas9 expertise and technology from CRISPR Therapeutics with access to deep disease-state knowledge and protein engineering capabilities from Bayer.